Comments
Loading...
Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) Forecast
NewsEarningsBio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) Stock Quotes, Forecast and News Summary
Bio-Rad Laboratories, Inc. Class B Common Stock Stock (NYSE: BIO/B) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
You can purchase shares of Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) through any online brokerage.
Who are Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) competitors?
Other companies in Bio-Rad Laboratories, Inc. Class B Common Stock’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the forecast, or price target, for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
Bio-Rad Laboratories, Inc. Class B Common Stock has a consensus price target of $433.43.
What is the current price for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B)?
The stock price for Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) is $334.85 last updated October 3, 2024 at 7:00 PM EDT.
Does Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) pay a dividend?
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
When is Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) reporting earnings?
Bio-Rad Laboratories, Inc. Class B Common Stock’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) going to split?
There is no upcoming split for Bio-Rad Laboratories, Inc. Class B Common Stock.